Page last updated: 2024-10-29

iproniazid and Dermatitis, Atopic

iproniazid has been researched along with Dermatitis, Atopic in 2 studies

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NARANJO, P1
HEIM, E1
KONZELMANN, M1
STORCK, H1

Other Studies

2 other studies available for iproniazid and Dermatitis, Atopic

ArticleYear
[Nialamide as a coadjuvant in the treatment of allergic eczema].
    Revista medica del Hospital General, 1961, May-10, Volume: 41

    Topics: Dermatitis, Atopic; Eczema; Iproniazid; Nialamide

1961
[The influence of niamid on the autonomic circulation in patients with atopic eczema].
    Praxis, 1961, Oct-12, Volume: 50

    Topics: Autonomic Nervous System; Biological Phenomena; Blood Circulation; Dermatitis, Atopic; Eczema; Ipron

1961